Gene · 6613
Papers2,290
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 2,290
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An "up" oriented methionine-aromatic structural motif in SUMO is critical for its stability and activity. | J Biol Chem | 2021 | 34274315 | PubTator, text mining | PubMed |
| Expression and Prognosis Analysis of SUMOylation Regulators in Oral Squamous Cell Carcinoma Based on High-Throughput Sequencing. | Front Genet | 2021 | 34267779 | PubTator, text mining | PubMed |
| SUMOylated Senataxin functions in genome stability, RNA degradation, and stress granule disassembly, and is linked with inherited ataxia and motor neuron disease. | Mol Genet Genomic Med | 2021 | 34263556 | PubTator, text mining | PubMed |
| cGAS-like receptors sense RNA and control 3'2'-cGAMP signalling in Drosophila. | Nature | 2021 | 34261127 | PubTator, text mining | PubMed |
| Molecular networks of the FOXP2 transcription factor in the brain. | EMBO Rep | 2021 | 34260143 | PubTator, text mining | PubMed |
| Differential effects of SUMO1 and SUMO2 on circadian protein PER2 stability and function. | Sci Rep | 2021 | 34257372 | PubTator, text mining | PubMed |
| SUMOylation modification-mediated cell death. | Open Biol | 2021 | 34255975 | PubTator, text mining | PubMed |
| Emerging Roles of Ubiquitin-Specific Protease 25 in Diseases. | Front Cell Dev Biol | 2021 | 34249948 | PubTator, text mining | PubMed |
| ZFP451-mediated SUMOylation of SATB2 drives embryonic stem cell differentiation. | Genes Dev | 2021 | 34244292 | PubTator, text mining | PubMed |
| PIAS1 potentiates the anti-EBV activity of SAMHD1 through SUMOylation. | Cell Biosci | 2021 | 34238351 | PubTator, text mining | PubMed |
| SUMO paralogue-specific functions revealed through systematic analysis of human knockout cell lines and gene expression data. | Mol Biol Cell | 2021 | 34232706 | PubTator, text mining | PubMed |
| Enzymatic Machinery of Ubiquitin and Ubiquitin-Like Modification Systems in Chondrocyte Homeostasis and Osteoarthritis. | Curr Rheumatol Rep | 2021 | 34216299 | PubTator, text mining | PubMed |
| Alternatives for the worse: Molecular insights into adverse effects of bisphenol a and substitutes during human adipocyte differentiation. | Environ Int | 2021 | 34186270 | PubTator, text mining | PubMed |
| Aberrant MCM10 SUMOylation induces genomic instability mediated by a genetic variant associated with survival of esophageal squamous cell carcinoma. | Clin Transl Med | 2021 | 34185429 | PubTator, text mining | PubMed |
| Targeting SUMOylation in Plasmodium as a Potential Target for Malaria Therapy. | Front Cell Infect Microbiol | 2021 | 34178724 | PubTator, text mining | PubMed |
| Post-Translational Modifications of Deubiquitinating Enzymes: Expanding the Ubiquitin Code. | Front Pharmacol | 2021 | 34177595 | PubTator, text mining | PubMed |
| A straightforward methodology to overcome solubility challenges for N-terminal cysteinyl peptide segments used in native chemical ligation. | Chem Sci | 2021 | 34164087 | PubTator, text mining | PubMed |
| Inhibition of SENP6 restrains cerebral ischemia-reperfusion injury by regulating Annexin-A1 nuclear translocation-associated neuronal apoptosis. | Theranostics | 2021 | 34158860 | PubTator, text mining | PubMed |
| Lamin post-translational modifications: emerging toggles of nuclear organization and function. | Trends Biochem Sci | 2021 | 34148760 | PubTator, text mining | PubMed |
| Matrix-screening reveals a vast potential for direct protein-protein interactions among RNA binding proteins. | Nucleic Acids Res | 2021 | 34133714 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6613/papers?page=30